Which MRI dye gives the best picture of heart damage?
NCT ID NCT03057561
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compared two contrast agents (Dotarem and Gadovist) used in cardiac MRI to see which provides clearer images of heart muscle damage. 120 adults with coronary artery disease or cardiomyopathy received one of the two dyes during their scan. Researchers rated image quality and tracked heart-related outcomes over time to see if one agent was better at linking scan findings to real-world health events.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Gadolinium-based contrast agents (Dotarem and Gadovist)
- What this could lead to
- If one contrast agent proves superior, it could improve heart MRI accuracy and help doctors better predict heart-related events.
- What could go wrong
- This is a small pilot study (120 people) comparing two already-approved agents, so major breakthroughs are unlikely. Results may not change current practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Can we predict which heart aneurysms will grow?
- Can a higher dose of adenosine sharpen heart scans?